310 related articles for article (PubMed ID: 19896699)
21. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
Sieuwerts AM; Meijer-van Gelder ME; Timmermans M; Trapman AM; Garcia RR; Arnold M; Goedheer AJ; Portengen H; Klijn JG; Foekens JA
Clin Cancer Res; 2005 Oct; 11(20):7311-21. PubMed ID: 16243802
[TBL] [Abstract][Full Text] [Related]
22. The differential effects of IL-1 and TNF-alpha on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells.
Shi J; Schmitt-Talbot E; DiMattia DA; Dullea RG
Inflamm Res; 2004 Aug; 53(8):377-89. PubMed ID: 15316669
[TBL] [Abstract][Full Text] [Related]
23. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
25. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma.
Chen C; Zhou H; Xu L; Liu X; Liu Z; Ma D; Chen Y; Ma Q
J Surg Oncol; 2010 Dec; 102(7):838-43. PubMed ID: 20872801
[TBL] [Abstract][Full Text] [Related]
27. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of ephrin-A5, a gene product of normal cartilage, in chondrosarcoma.
Kalinski T; Röpke A; Sel S; Kouznetsova I; Röpke M; Roessner A
Hum Pathol; 2009 Dec; 40(12):1679-85. PubMed ID: 19695673
[TBL] [Abstract][Full Text] [Related]
29. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of matrix metalloproteinases and tissue-derived inhibitors of metalloproteinase in fetal and adult skins.
Chen W; Fu X; Ge S; Sun T; Sheng Z
Int J Biochem Cell Biol; 2007; 39(5):997-1005. PubMed ID: 17409012
[TBL] [Abstract][Full Text] [Related]
31. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Söderström M; Aro HT; Ahonen M; Johansson N; Aho A; Ekfors T; Böhling T; Kähäri VM; Vuorio E
APMIS; 2001 Apr; 109(4):305-15. PubMed ID: 11469503
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of collagen and tissue inhibitors of matrix metalloproteinase in colonic diverticular disease.
Mimura T; Bateman AC; Lee RL; Johnson PA; McDonald PJ; Talbot IC; Kamm MA; MacDonald TT; Pender SL
Dis Colon Rectum; 2004 Mar; 47(3):371-8; discussion 378-9. PubMed ID: 14991500
[TBL] [Abstract][Full Text] [Related]
34. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas.
Dornauer K; Söder S; Inwards CY; Bovee JV; Aigner T
Pathol Int; 2010 May; 60(5):365-72. PubMed ID: 20518886
[TBL] [Abstract][Full Text] [Related]
35. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage.
Böhm BB; Aigner T; Gehrsitz A; Blobel CP; Kalden JR; Burkhardt H
Arthritis Rheum; 1999 Sep; 42(9):1946-50. PubMed ID: 10513811
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR.
Asp J; Brantsing C; Lövstedt K; Benassi MS; Inerot S; Gamberi G; Picci P; Lindahl A
Int J Oncol; 2005 Dec; 27(6):1577-82. PubMed ID: 16273214
[TBL] [Abstract][Full Text] [Related]
38. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
39. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
40. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
